Table 3A.
Comparison of pre-transplant non-HLA antibodies between ABMRhDSApos and ABMRhDSAneg cases.
| ABMRhDSApos (n = 38)* | ABMRhDSAneg (n = 14)* | p-value | |
|---|---|---|---|
| Pre-transplant AT1R-Ab (yes, %) | 16 (50) | 0 (0) | 0.029 |
| Pre-transplant ETAR-Ab (yes, %) | 10 (31.3) | 0 (0) | 0.16 |
| Pre-transplant MICA-Ab (yes, %) | 3 (9.4) | 0 (0) | 1.00 |
| Pre-transplant EC-XM (positive, %)# | 1 (4.5) | 2 (28.6) | 0.14 |
*From 32 ABMRhDSApos and 7 ABMRhDSAneg cases with pre-transplant available samples. #From 22 ABMRhDSApos and 7 ABMRhDSAneg cases.
The bold values represent those p-values that are statistically significant.